Manufacturing, Gene Therapies

Frontrunners in Automated Cell and Gene Therapy Manufacturing

August 04, 2024

Innovative solutions are making personalized cell and gene therapies accessible to all.

Univercells and University of Pennsylvania Expand Agreement for Gene Therapy Program

July 25, 2024

Univercells and the University of Pennsylvania are expanding their collaboration to evaluate certain bioreactors with the aim to scale up gene therapy manufacturing.

uniQure to Sell Its Commercial Gene Therapy Manufacturing Operations in Massachusetts to Genezen

July 10, 2024

The acquisition of uniQure’s Lexington, Mass., manufacturing operations will boost Genezen’s late-phase and commercial gene therapy development and manufacturing services.

Sarepta’s Elevidys for Duchenne Muscular Dystrophy Gets Expanded FDA Approval

June 26, 2024

Sarepta Therapeutics received expanded approval from FDA for Elevidys in the treatment of DMD in non-ambulatory patients as ell as ambulatory patients.

The Benefit of Long-Read Sequencing in Gene Therapies

June 18, 2024

Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview.

The Need for Automated and Standardized CGT Manufacturing (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.

Trends and Obstacles in the CGT Field (BIO 2024)

June 07, 2024

Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs.

CGT Catapult and CATTI Establish Shared Training Standards for Advanced Therapies

June 04, 2024

CGT Catapult and CATTI aim to standardize advanced therapy manufacturing with new aligned training standards.

Seeking Excellence with CRISPR (BIO 2024)

June 04, 2024

Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.

CGT Catapult and Cellular Origins Team Up to Develop Automated CGT Manufacturing

June 01, 2024

CGT Catapult will implement Cellular Origins' robotic platform in its Stevenage, UK, site to establish automated CGT manufacturing.